Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016

BACKGROUND: Anticoagulation among patients with cancer and atrial fibrillation is challenging due to elevated risk of bleeding and stroke. We characterized use of oral anticoagulants among patients with cancer and non‐valvular atrial fibrillation (NVAF). METHODS: We used Surveillance, Epidemiology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardeshirrouhanifard, Shirin, An, Huijun, Goyal, Ravi K., Raji, Mukaila A., Segal, Jodi B., Alexander, G. Caleb, Mehta, Hemalkumar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302858/
https://www.ncbi.nlm.nih.gov/pubmed/35364622
http://dx.doi.org/10.1002/phar.2679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302858/
https://www.ncbi.nlm.nih.gov/pubmed/35364622
http://dx.doi.org/10.1002/phar.2679

Ejemplares similares